Conclusively, SOCS 1 and 3 methylation and its tumour growth suppression activity demonstrate the importance of the constitutive activation of the JAK2/STAT3 pathway in the development of HCC (Yoshikawa et al., 2001; Niwa et al., 2005). The gene discussed is STAT3; the disease is hepatocellular carcinoma.